Next Article in Journal
Animal Toxins Can Alter the Function of Nav1.8 and Nav1.9
Next Article in Special Issue
Clinical Uses of Botulinum Neurotoxins: Current Indications, Limitations and Future Developments
Previous Article in Journal
Molecular Motions as a Drug Target: Mechanistic Simulations of Anthrax Toxin Edema Factor Function Led to the Discovery of Novel Allosteric Inhibitors
Article Menu

Export Article

Open AccessArticle
Toxins 2012, 4(8), 605-619; doi:10.3390/toxins4080605

Botulinum Neurotoxin A Injections Influence Stretching of the Gastrocnemius Muscle-Tendon Unit in an Animal Model

1
UniversitätsKlinikum Heidelberg, Stiftung Orthopädische Universitätsklinik, Schlierbacher Landstrasse 200a, Heidelberg, 69118, Germany
2
Department of Orthopaedic Surgery, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA
3
The Neuroscience Program, Wake Forest University Graduate School of Arts and Sciences, Medical Center Boulevard, Winston-Salem, NC 27157, USA
4
Department of Biomedical Engineering, Wake Forest School of Medicine and VT-WFU School of Biomedical Engineering and Sciences, Medical Center Boulevard, Winston-Salem, NC 27157, USA
*
Authors to whom correspondence should be addressed.
Received: 27 June 2012 / Revised: 9 August 2012 / Accepted: 10 August 2012 / Published: 13 August 2012
(This article belongs to the Special Issue Clinical Use of Botulinum Toxins)
View Full-Text   |   Download PDF [988 KB, 21 August 2012; original version 13 August 2012]   |  

Abstract

Botulinum Neurotoxin A (BoNT-A) injections have been used for the treatment of muscle contractures and spasticity. This study assessed the influence of (BoNT-A) injections on passive biomechanical properties of the muscle-tendon unit. Mouse gastrocnemius muscle (GC) was injected with BoNT-A (n = 18) or normal saline (n = 18) and passive, non-destructive, in vivo load relaxation experimentation was performed to examine how the muscle-tendon unit behaves after chemical denervation with BoNT-A. Injection of BoNT-A impaired passive muscle recovery (15% vs. 35% recovery to pre-stretching baseline, p < 0.05) and decreased GC stiffness (0.531 ± 0.061 N/mm vs. 0.780 ± 0.037 N/mm, p < 0.05) compared to saline controls. The successful use of BoNT-A injections as an adjunct to physical therapy may be in part attributed to the disruption of the stretch reflex; thereby modulating in vivo passive muscle properties. However, it is also possible that BoNT-A injection may alter the structure of skeletal muscle; thus modulating the in vivo passive biomechanical properties of the muscle-tendon unit. View Full-Text
Keywords: Botulinum Neurotoxin; spasticity treatment; muscle tone; passive muscle biomechanics Botulinum Neurotoxin; spasticity treatment; muscle tone; passive muscle biomechanics
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Haubruck, P.; Mannava, S.; Plate, J.F.; Callahan, M.F.; Wiggins, W.F.; Schmidmaier, G.; Tuohy, C.J.; Saul, K.R.; Smith, T.L. Botulinum Neurotoxin A Injections Influence Stretching of the Gastrocnemius Muscle-Tendon Unit in an Animal Model. Toxins 2012, 4, 605-619.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top